CD4-specific DARPins (Population Council/University of Zurich)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD4-specific DARPins (Population Council/University of Zurich)
Drug Alias NameCD4-specific designed ankyrin repeat proteins (Population Council/University of Zurich)DARPin 23.2DARPin 25.2DARPin 57.2DARPin 29.2 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of ZurichPopulation Council, Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A